Publications
Our latest thinking on the governance of emerging technologies
Featured
Recent and relevant analysis
Promise and peril
We reviewed more than a hundred wellness neurotechnology company websites — examining their marketing claims, the evidence behind them, and what they do or don’t disclose about regulatory status.
Introducing “Neurotech between wellness and medicine”
Consumer neurotechnology devices are multiplying fast — and slipping through the gap between medical regulation and the consumer market. CFG examines the tensions driving this grey zone, and what regulators can do about it.
Who is the bully? How platform power magnifies online harm
Europe’s cyberbullying action plan risks missing the real culprit. Nicoleta Prutean argues that when platforms systematically exploit vulnerability for profit, the bully is the system itself.
Neurotechnology deserves an EU research moonshot
Europe is home to world-class neuroscience, yet lacks a coherent strategy to match. Pawel Swieboda argues the EU needs a dedicated neurotechnology moonshot before rivals pull ahead in the race to interface with the human brain.
Announcing ‘Tech & the Planet’: A CFG project to advance Europe’s tech and climate goals together
Europe’s tech ambitions and climate commitments are increasingly being governed separately. This piece explores how the EU can align both before infrastructure decisions lock in incompatible pathways.
Moonshots have launch windows: Europe’s narrowing opportunity for biotech leadership
The EU’s Biotech Act could define Europe’s next industrial frontier. But success will depend on clear missions, accountable leadership, and permanent capabilities.
News & announcements
Find out what's new with CFG
Policy input
Public and institutional consultation submissions